No Detail Found!

Comparison of in Vitro Susceptibility of Sarcoptes scabiei var. hominis to Topical 5%permethrin and Topical 1% Ivermectin.

Author(s)
Nighat Akbar Department of Dermatology, Military Hospital, Rawalpindi, Pakistan
Nadia Iftikhar Department of Dermatology, Combined Military Hospital, Jhelum, Pakistan
Abstract
Objective To compare the in vitro susceptibility of Sarcoptes scabiei var.hominis to 5% permethrin and 1% ivermectin. MethodsA randomized, controlled trial was conducted in OPD, Dermatology Department, Military Hospital, Rawalpindi, Pakistan over a period of six months from December 17, 2014 to June 16, 2015.A total of 80 mites from 80 patients were taken. Mites were randomly allocated to two groups: group A (5% permethrin) and group B (1% ivermectin). 5% permethrin and 1% ivermectin were applied in a thin film over a glass slide. Live mites were gently transferred to the glass slide. These were inspected microscopically for leg movements at an hourly interval for 6 hours. Death was declared once all leg movements had ceased. All mites which died within 6 hours were considered as susceptible to drug, while mites having active leg movements even after 6 hours were considered as non-susceptible. Results There were 35 (84.5%) mites which showed invitro susceptibility in the group A (5% permethrin), whereas all the mites from group B (1% ivermectin) were susceptible. ConclusionThe in vitro susceptibility was statistically significant (p=0.021) in both the groups. 1% ivermectin was better than 5% permethrin in terms of invitro susceptibility.
Publication Details
Page(s) 99-106
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 26, Issue: 2, Year: 2016

Request the full text from PASTIC

References
FullerLC, 2013.Epidemiology of scabies,Curr Opin Infect Dis 26 123 -6
HeukelbachJ,MazigoHD,UgbomoikoUS, 2013.Impact of scabies in resource-poor communities,Curr Opin Infect Dis 26 127 -32
HayRJ,SteerAC,EngelmanD,WaltonS., 2012.Scabies in the developing world--its prevalence, complications, and management,Clin Microbiol Infect 18 313 -23
MicaliG,LacarrubbaF,VerzìAE,NascaMR, 2015.Low-cost equipment for diagnosis and management of endemic scabies outbreaks in underserved populations,Clin Infect Dis 60 327 -9
LeungV,MillerM., 2011.Detection of scabies: A systematic review of diagnostic methods,Can J Infect Dis Med Microbiol 22 143 -6
Le CleachL,ChosidowO., 2011.Commentary on "Interventions for treating scabies",Evid Based Child Health 1865 -6
RanjkeshMR,NaghiliB,GoldustM,RezaeeE., 2012.The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies, 59 189 -94
LokugeB,KopczynskiA,WoltmannA,AlvoenF,ConnorsC,GuyulaT, 2014.Crusted scabies in remote Australia, a new way forward: lessons and outcomes from the East Arnhem Scabies Control Program,Med J Aust 200 644 -8
GonzalezP,GonzálezF,UenoK., 2012.Ivermectin in human medicine, an overview of the current status of its clinical applications,Curr Pharm Biotechnol 13 1103 -9
ThuanNH,PandeyRP,SohngJK, 2014.Recent advances in biochemistry and biotechnological synthesis of avermectins and their derivatives,ApplMicrobiolBiotechnol 98 7747 -59
ŌmuraS,CrumpA, 2014.Ivermectin: panacea for resource-poor communities? Trends Parasitol, 30 445 -55
WebsterJP,MolyneuxDH,HotezPJ,FenwickA, 2014.The contribution of mass drug administration to global health: past, present and future,Philos Trans R Soc LondB Biol Sci 369 20130434 -
RizviSDA,IftikharN,BatoolF, 2011.Effectiveness of oral ivermectin for eradicating infesting mites in patients of scabies,J Pak Assoc Dermatol 21 87 -92
GoldustM,RezaeeE,RaghifarR, 2013.Treatment of scabies: the topicalivermectin vs,permethrin 2 59 79 -84
ChhaiyaSB,PatelVJ,DaveJN,MehtaDS,ShahHA, 2012.Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies,Indian J Dermatol Venereol Leprol 78 605 -10
AlasaadS,RossiL,HeukelbachJ,PérezJM,HamarshehO,OtiendeM, 2014.The neglected navigating web of the incomprehensibly emerging and re-emerging Sarcoptes mite,Infect Genet Evol 17 253 -9
AndriantsoanirinaV,IzriA,BotterelF,FouletF,ChosidowO,DurandR, 2014.Molecular survey of knockdown resistance to pyrethroids in human scabies mites,Clin Microbiol Infect 20 O139 -O141
DongK,DuY,RinkevichF,NomuraY,XuP,WangL, 2014.Molecular biology of insect sodium channels and pyrethroid resistance,Insect Biochem Mol Biol 50 1 -17
FischerK,HoltD,CurrieB,KempD, 2012.Important clinical consequences explained by new molecular studies,AdvParasitol 79 339 -73
ChhaiyaSB,MehtaDS,KatariaBC, 2012.Ivermectin: pharmacology and therapeutic applications,Int J Basic Clin Pharmacol 1 132 -9
AggarwalG,RathorePK, 2014.Comparative study to test efficacy of topical permethrin and oral ivermectin in the management of scabies-a prospective randomized, single blinded controlled study,Nat J Integ ResMed 5 57 -60
StoevesandtJ,CarléL,LeverkusM,Hamm H, 2012.Control of large institutional scabies outbreaks,J Dtsch Dermatol Ges 10 637 -47
WorthC,FenglerG,WalterB,LiesenfeldO, 2012.Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin,Pediatr Dermatol 29 430 -6
ElstonCA,ElstonDM, 2013.Treatment of common skin infections and infestations during pregnancy,Dermatol Ther 26 312 -20
ButlerDC,HellerMM,MuraseJE,Lactation. J AmAcad Dermatol, 2014.Safety of dermatologic medications in pregnancy and lactation: Part II, 70 417 -e1
FujimotoK,KawasakiY,MorimotoK,KikuchiI,KawanaS, 2014.Treatment for crusted scabies: limitations and side effects of treatment with ivermectin,J Nippon Med Sch 81 157 -63
ManjhiPK,SinhaRI,KumarM,SinhaKI, 2014.Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies,JClin DiagnRes 8 HC01 -4
HaasN,LindemannU,FrankK,SterryW,LademannJ,KatzungW. Rapid, 2002.and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies,Arch Dermatol 138 1618 -9
KomodaM,AkagiK,YuzawaK,YoshimasuT,YamamotoY, 2015.Experimental study of pharmacokinetics of external, whole‐body bathing application of ivermectin,J Dermatol 42 87 -89
WaltonSF,MyerscoughMR,CurrieBJ, 2000.Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var,hominis. Trans R Soc Trop Med Hyg 94 92 -6
0

Citations

0

Downloads

83

Views